FECAL LACTOFERRIN AND CALPROTECTIN AS SURROGATE MARKERS OF MUCOSAL HEALING: POST-HOC ANALYSIS FROM THE PURSUIT SC INDUCTION STUDY

(1) Gastroenterology,1U für Innere Medizin III and McMaster U,Vienna and Hamilton,Austria

(2) Immunology,Janssen R&D, LLC,Spring House,United States

(3) Gastroenterology,CHU,Lille,France

(4) Gastroenterology,5th Military Hospital,Krakow,Poland

(5) Gastroenterology,Military Medical Academy,Belgrade,Serbia

(6) Gastroenterology,Oregon Health Sciences U,Portland,United States

(7) Gastroenterology,Alfred Hospital,Melbourne,Australia

(8) Gastroenterology,U Hospital, Gasthuisberg,Leuven,Belgium

(9) Gastroenterology,Robarts Research Institute, U Western Ontario,London,Canada

(10) Gastroenterology,U California San Diego,La Jolla,United States

(11) Biostats,Janssen R&D, LLC,Spring House,United States



This item was part of UEG Week 2015

This item can be cited as: United European Gastroenterology Journal; 2015: 2 (Supplement 1)